Virax Biolabs Group Ltd (VRAX) Current Assets (2021 - 2025)

Virax Biolabs (VRAX) has 5 years of Current Assets data on file, last reported at $4.9 million in Q1 2025.

• In Q1 2025, Current Assets rose 11.72% year-over-year to $4.9 million; the TTM figure through Mar 2025 stood at $4.9 million (up 11.72% YoY), while the FY2025 annual figure was $4.9 million, up 11.72% from the prior year.
• Current Assets grew to $4.9 million in Q1 2025, from $4.4 million in the prior quarter.
• Across five years, Current Assets topped out at $9.6 million in Q1 2023 and bottomed at $39621.0 in Q1 2021.
• A 5-year average of $3.8 million and a median of $4.4 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets jumped 19679.93% — and 2024, when it slumped 54.53%.
• Year by year, Current Assets stood at $39621.0 in 2021, then grew by 22.93% to $48706.0 in 2022, then jumped by 19679.93% to $9.6 million in 2023, then plunged by 54.53% to $4.4 million in 2024, then advanced by 11.72% to $4.9 million in 2025.
• The last three Current Assets figures came in at $4.9 million (Q1 2025), $4.4 million (Q1 2024), and $9.6 million (Q1 2023), per Business Quant data.

Peer Comparison